Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Berkshire Hathaway (BRK.A) Before the Bell — What to Know on Nov. 7, 2025

Ahead of Friday’s U.S. open, Berkshire Hathaway’s record cash pile, a fresh yen-bond plan, wildfire-litigation headlines at its utility arm, and Apple‑related moves are the key drivers to watch for BRK.A and its more liquid twin, BRK.B.


At a glance

  • Last trade (overnight): BRK.A $739,900, BRK.B $493.15 (latest prints in early U.T.C. hours; premarket trading in BRK.A is typically thin).
  • Macro tone this morning: A firmer U.S. dollar and softer Treasury yields amid an extended U.S. government shutdown that has delayed some official data releases, keeping traders focused on private labor indicators and the December Fed meeting odds. [1]
  • Fresh corporate thread: Berkshire has hired banks for a potential yen‑denominated bond sale—a financing channel it has used to fund Japan investments and other needs. [2]
  • Recent fundamentals: In Q3, Berkshire posted $13.49B in operating earnings and $30.8B in net earnings; segment results were led by insurance and steady contributions from BNSF and Berkshire Hathaway Energy (BHE). [3]

Where BRK.A stands after Thursday

Berkshire’s Class A shares last changed hands at $739,900 overnight, while Class B ended at $493.15. For context, Berkshire notched its all‑time high earlier this year and remains within its 52‑week range heading into today’s session. [4]


What’s new (Friday, Nov. 7)

1) Macro setup favors caution. The U.S. dollar is on track for a modest weekly gain, with investors parsing softer private‑sector labor signals while the government shutdown delays some official releases. Lower yields and data uncertainty matter for Berkshire because its enormous cash earns less if rates fall further. [5]

2) Apple watch (portfolio sensitivity). Apple’s Apple TV+ service was briefly down overnight but has been restored, a minor operational blip for Berkshire’s largest equity holding; broader AI/platform headlines also keep AAPL in focus pre‑bell. [6]

3) Funding window in Japan. Multiple reports indicate Berkshire plans another yen‑bond sale, naming BofA Securities and Mizuho as lead underwriters—consistent with its frequent Samurai issuance in recent years. A move would add funding flexibility while the company sits on record cash. [7]

4) Subsidiary risk in view. Earlier this week, Berkshire’s utility PacifiCorp warned that an accelerated Oregon wildfire trial schedule could strain liquidity and pressure its credit metrics—an overhang investors continue to monitor. [8]


By the numbers (Q3 2025 snapshot)

  • Operating earnings:$13.49B (up from $10.09B a year ago).
  • Net earnings:$30.80B (includes investment gains; Berkshire cautions investors not to use GAAP net as a performance proxy).
  • Insurance underwriting:$2.37B; Insurance investment income:$3.18B.
  • BNSF:$1.45B; Berkshire Hathaway Energy:$1.49B.
  • Insurance “float”:~$176B at Sept. 30, 2025. [9]

Berkshire also ended Q3 with a record cash balance of roughly $381.7B, continued to be a net seller of equities for the 12th straight quarter, and did not repurchase shares for a fifth consecutive quarter. These choices underscore a cautious stance as Warren Buffett prepares to hand the CEO role to Greg Abel at year‑end. [10]


Portfolio threads to watch

  • Apple & Bank of America: Analysts at Barron’s inferred from Berkshire’s 10‑Q that it may have trimmed both stakes in Q3; definitive details are due in next week’s 13F filing. Any confirmation could influence sentiment in both names and, by extension, BRK. [11]
  • Japan trading houses: Reuters highlighted upbeat guidance at Mitsui, one of the five sōgō shōsha where Berkshire holds ~10% stakes, keeping that theme in play. [12]
  • Chemicals acquisition: Berkshire has agreed to acquire Occidental’s OxyChem for $9.7B, with closing targeted for Q4—an example of redeploying capital into industrial cash generators. [13]

Leadership & communication calendar

  • Nov. 10: Warren Buffett will release a letter to his children and to Berkshire shareholders; Greg Abel takes over authorship of the annual shareholder letter beginning in February. Markets will parse both for capital‑allocation and buyback/dividend signals. [14]
  • Nov. 14 (expected):13F holdings report—clarity on any Q3 changes, notably in Apple and Bank of America. [15]

What could move BRK.A/BRK.B today

  1. Rates & the dollar: A further slide in yields (or a stronger dollar) as the shutdown drags on could sway expectations for Berkshire’s cash income and insurer investment returns. [16]
  2. AAPL/financials tape: Outsized moves in Apple or large financials ripple through Berkshire’s look‑through earnings and investor sentiment. [17]
  3. Subsidiary headlines: Any wildfire‑litigation or regulatory updates at BHE/PacifiCorp, or railroad volume commentary at BNSF, would be material. [18]
  4. Capital markets: Confirmation/details on the yen‑bond could rekindle speculation about large‑ticket capital deployment (including Japan or industrial assets). [19]

Bottom line

Berkshire heads into Friday’s open with fortress cash, a conservative buy/sell posture, and a tidy earnings print for Q3—but with eyes on Japan funding, wildfire risks at BHE, and next week’s 13F for any proof of portfolio trims. Macro remains the near‑term driver: shutdown‑blurred data and rate‑path uncertainty are likely to set the tone for BRK.A/BRK.B into the weekend. [20]


Sources & further reading

  • Berkshire Q3 2025 News Release (results by segment; float and share count). [21]
  • Reuters: Record cash, net seller posture; management transition context. [22]
  • Reuters: Dollar setup and shutdown implications for data and yields. [23]
  • Bloomberg / Reuters wire (via TradingView): Berkshire yen‑bond plan. [24]
  • Manufacturing Dive: Berkshire to acquire OxyChem for $9.7B. [25]
  • Reuters:PacifiCorp wildfire‑trial schedule and liquidity warning. [26]
  • Barron’s: Inferred Q3 Apple/Bank of America trims; 13F timing. [27]
  • Reuters:Mitsui forecast update; Berkshire stake. [28]
  • Live price reference: BRK.A/BRK.B latest prints.

Note: Prices and premarket indications referenced above reflect the latest available data prior to the U.S. opening bell; Berkshire’s Class A premarket liquidity is often sparse, so traders typically watch BRK.B for a cleaner early read.

Warren Buffett's Advice to Investors for 2026

References

1. www.reuters.com, 2. www.bloomberg.com, 3. berkshirehathaway.com, 4. www.tradingview.com, 5. www.reuters.com, 6. www.reuters.com, 7. www.tradingview.com, 8. www.reuters.com, 9. berkshirehathaway.com, 10. www.reuters.com, 11. www.barrons.com, 12. www.reuters.com, 13. www.manufacturingdive.com, 14. www.reuters.com, 15. www.barrons.com, 16. www.reuters.com, 17. www.reuters.com, 18. www.reuters.com, 19. www.bloomberg.com, 20. www.reuters.com, 21. berkshirehathaway.com, 22. www.reuters.com, 23. www.reuters.com, 24. www.bloomberg.com, 25. www.manufacturingdive.com, 26. www.reuters.com, 27. www.barrons.com, 28. www.reuters.com

Stock Market Today

  • Pool Corp Named a Top 25 Dividend Giant With 2.01% Yield
    November 7, 2025, 8:52 AM EST. Pool Corp (ticker: POOL) was named a Top 25 Dividend Giant by ETF Channel, supported by $58.66B in ETF ownership and a solid 2.01% yield. The DividendRank metrics highlight a long-running quarterly dividend history and favorable multi-year growth in key fundamentals. The stock pays an annualized $5 dividend, distributed quarterly, with the latest ex-dividend date recorded as 11/12/2025. As ETF ownership underscores steady income demand, investors may weigh past dividend reliability when assessing whether the current payout can continue amid the firm's growth trajectory. The study sits among the broader list of Dividend Giants widely held by ETFs.
  • FHLC Implied Target at $81.28: Analysts See ~16% Upside While XERS/MLYS/IRMD Stand Out
    November 7, 2025, 8:50 AM EST. Analysts using ETF Channel data peg the Fidelity MSCI Health Care Index ETF (FHLC) at an implied target of $81.28, versus a recent price near $70.14. That equates to about 15.88% upside to the target. Among FHLC's holdings, Xeris Biopharma (XERS) shows the strongest upside with a target of $10.67 (from $7.72, 38.16% higher); Mineralys Therapeutics (MLYS) targets $45.00 (vs $37.01, 21.59%); and iRadimed (IRMD) targets $99.00 (vs $84.57, 17.06%). The article notes questions about whether these targets are justified and warns that lofty targets can precede downgrades, suggesting investors perform further research.
  • TRGP Named Top Socially Responsible Dividend Stock by Dividend Channel
    November 7, 2025, 8:48 AM EST. TRGP has been named a Top Socially Responsible Dividend Stock by Dividend Channel, highlighting a DividendRank-driven profile with a 2.4% yield. The designation reflects ESG considerations-environmental, social, and governance criteria-used by asset managers when assessing investments. TRGP also appears in ESG-focused ETFs: SUSA (0.72% of holdings) and DSI (0.14%). The stock pays an annualized dividend of $4 per share, quarterly, with the ex-date on 10/31/2025. Operates in the Oil & Gas Refining & Marketing sector. The article notes the importance of dividend history in judging the likelihood of continued payments, and positions TRGP among peers like CVX and SU.
  • EXC Named a Top 10 Dividend-Paying Utility Stock by Dividend Channel
    November 7, 2025, 8:46 AM EST. Exelon Corp (EXC) has been named a Top 10 dividend-paying utility stock by Dividend Channel's weekly DividendRank report, highlighting a favorable mix of valuations and profitability. The stock trades around $45.71 with a price-to-book of 1.6 and yields 3.50% annually, versus the utility universe average of 3.4% yield and 2.8x P/B. The report emphasizes EXC's strong quarterly dividend history and solid long-term growth metrics. DividendRank aims to identify the most profitable, attractively valued names for further research. Exelon's annualized dividend is $1.6 per share, paid quarterly, with the most recent ex-dividend date listed as 11/10/2025. Investors eyeing value and income may view EXC as a compelling idea within the utility space.
  • Marsh & McLennan Stock Prediction: Analysts See ~21% Upside by 2027
    November 7, 2025, 8:44 AM EST. Marsh & McLennan (NYSE: MMC) trades near $177 and faces modest upside according to analysts. The average target ~ $214 implies about 21% upside, with a tight range (high $258, low $181) and a mix of 4 Buys, 2 Outperforms, 14 Holds, 1 Underperform, 1 Sell. The story centers on steady fundamentals: revenue growth of 6-7% annually through 2027, potential operating margins approaching 27%, and a forward P/E around 18x. TIKR's Guided Valuation Model suggests a ~$215 by 2027 (about 9.5% annualized returns). The stock is viewed as a stable, high-quality compounder, with dividend growth and disciplined capital management offsetting risks of multiple expansion. Investors expect reliable earnings growth rather than aggressive expansion, with MMC likely to outperform in stable markets but limited upside without accelerating earnings.
Meta’s AI Revolution Unleashed: July 2025 Breakthroughs, Billion‑Dollar Bets & Backlash
Previous Story

Meta Platforms (META) Pre‑Market Update Today — November 7, 2025: Reuters scam‑ads bombshell, fresh AI‑training lawsuit, and what it means for the stock

TSMC Stock Skyrockets on AI Boom — Analysts See More Upside
Next Story

TSMC (TSM) Pre‑Market Briefing, Nov 7, 2025: Jensen Huang Visits Taiwan Partner, Taiwan Exports Soar on AI Demand, and 2026 Price‑Hike Reports Surface

Go toTop